Power Solutions International 2026 EV/EBITDA valuation

Power Solutions International, Inc. (PSIX)
By@hypertonx
Assumptions as of 2026-10-22
USD
Updated Oct 22, 2026 · Revised 14 times
Download Excel

Power Solutions International 2026 EV/EBITDA valuation

2026 EV/EBITDA valuation refreshed after reviewing PSIX's Q2 2026 10-Q, earnings release, and call transcript. Revenue is anchored to first-half actual sales plus second-half sales approximately in line with second-half 2025. The margin assumption gives credit to the 17.6% Q2 adjusted EBITDA margin while respecting management's cautions on Wisconsin ramp costs, product mix, oil-and-gas softness, and shipment timing. Q2 reported cash, debt, and diluted shares replace prior anchors; the multiple remains below hypergrowth levels.

as of 2026-10-22

Fair value per share
$38.49
Upside / downside
-15.6%
2026E adjusted EBITDA
$104.8
Implied enterprise value
$890.6
Net debt
$2.6
Implied equity value
$888.0

Balance sheet

$70.06
$72.65

Market

$45.63
Latest PSIX quote · updated Oct 23, 2026 2:00 PM MDT
23.072

Operating assumptions

15.5%
$676.00

Valuation assumptions

8.50

Sources

  1. October 22: investigated -9.03% daily move through indexed issuer activity, release discovery and web searches. No newly verified quantified issuer change supports altering the existing operating assumptions. Preserve methodology and financial anchors; update regular-session reference price and market-relative outputs. Exact company-specific price attribution remains unconfirmed. (accessed 2026-10-22)
  2. Regular-session reference $47.17 retrieved 2026-10-22T15:22:04.360675-06:00. Quote updates alone do not change operating assumptions. (accessed 2026-10-22)
  3. October 21: investigated +7.06% to $51.85. No fresh quantified issuer catalyst verified; earnings remain scheduled November 5. Retain $676M revenue, 15.5% EBITDA margin and 8.5x. The known $220M facility is capacity, not cash drawn; complete debt/cash/fees bridge and legacy P/E-monitoring conflict remain open. — investors.psiengines.com (accessed 2026-10-21)
  4. October 19 Model Edge reference PSIX price $49.03; provider/refresh timestamp 2026-10-19T15:24:42.775087-06:00. Retrieval timestamps are not trade timestamps or asserted official closing prints. Financial anchors retain their separately disclosed dates. (accessed 2026-10-19)
  5. October 19, 2026: Investigated the 6.43% rise. Targeted filing/transcript and web searches found no newly verified quantified operating catalyst; November 5 earnings timing and the previously disclosed $220M credit facility are not new earnings or cash. Preserve $676M revenue, 15.5% adjusted EBITDA margin and 8.5x; refresh price only. — modeledge.ai (accessed 2026-10-19)
  6. October 16 Model Edge regular-session PSIX reference $46.07, refreshed 2026-10-16T15:05:07.231661-06:00. Retrieval time is not trade time. Scope and separate financial-anchor changes are described in refresh context. (accessed 2026-10-16)
  7. October 15 Model Edge regular-session PSIX reference $50.62, refreshed 2026-10-15T15:04:35.92758-06:00. Retrieval time is not trade time. Scope and separate financial-anchor changes are described in refresh context. (accessed 2026-10-15)
  8. October 14 Model Edge regular-session reference PSIX price $46.605, refreshed 2026-10-14T14:58:22.490591-06:00. Price refresh changes market-relative outputs; separate evidence/relative-method changes are described below. — modeledge.ai (accessed 2026-10-14)
  9. October 13 Model Edge regular-session reference PSIX price $53.14, refreshed 2026-10-13T15:02:11.103752-06:00. Price refresh changes market-relative outputs; separate evidence/relative-method changes are described below. — modeledge.ai (accessed 2026-10-13)
  10. Issuer confirms November 5 Q3 results/call; no fresh guidance. — investors.psiengines.com (accessed 2026-10-13)
  11. October 8 Model Edge reference PSIX price $48.5, refreshed 2026-10-08T15:00:48.834204-06:00. Market-relative outputs use this quote; intrinsic assumptions only change on evidence. (accessed 2026-10-08)
  12. October 7 Model Edge reference PSIX quote $51.63, refreshed 2026-10-07T15:03:00.707654-06:00. Market-relative outputs use this price; valuation changes are separately explained. (accessed 2026-10-07)
  13. October 7 price +7.72%. No new quantified issuer catalyst found in latest filings/releases or web search. Existing September30 $220M facility is capacity, with $35M actual draw and $15M repayment already known; do not add gross capacity as cash. Keep revenue676M,15.5%EBITDAmargin,8.5x and existing balance-sheet basis; $38.490075 unchanged. — modeledge.ai (accessed 2026-10-07)
  14. October 6 Model Edge reference PSIX quote $47.93, refreshed 2026-10-06T15:02:51.19658-06:00. Price changes refresh market-relative outputs; evidence-supported valuation changes are separately described. (accessed 2026-10-06)
  15. October 6: price rose 6.82% to $47.93. Company-specific filing/press discovery and news searches did not verify a fresh company-specific catalyst or changed operating guidance. The September 30 revolver expansion was already reviewed and is borrowing capacity, not all new cash. Retain $676M forward revenue, 15.5% EBITDA margin, 8.5x EV/EBITDA and existing June balance-sheet/share anchors. User growth, margin and working-capital monitors require the next quarterly evidence; a daily quote is insufficient to rewrite them. — psiengines.gcs-web.com (accessed 2026-10-06)
  16. September 30 Modeledge reference PSIX price $45.97, refreshed 2026-09-30T15:27:35.823908-06:00. This quote refresh changes market-relative outputs; any intrinsic effects are separately explained. For USAU only, the existing financing-price formula mechanically links valuation to price. (accessed 2026-09-30)
  17. September 30 8-K and release confirm a $220M committed revolving facility to September 2029, replacing $135M capacity. SOFR spread falls 2.60% to 1.80%; $35M was borrowed and $15M old principal plus about $0.1M interest/fees repaid. Do not book $220M as cash or debt. September settlement balances cannot be reconciled completely to June anchors without interim cash/debt movements and other fees. Preserve June-based debt/cash and intrinsic value; record better liquidity and covenant/control conditions without inventing a live balance sheet. — modeledge.ai (accessed 2026-09-30)
  18. Reviewed August Forms 3/4 in the complete retrieved window: CEO award is 5,867 phantom units settled only in cash over 2027-2029. Do not add them as common shares. No new operating guidance or debt evidence in reviewed sources. (accessed 2026-09-14)
  19. September 14 Modeledge reference PSIX share price $39.46 retrieved after the regular U.S. close. Quote updates affect market-relative outputs; forecast changes, if any, are separately identified. (accessed 2026-09-14)
  20. Q2 2026 10-Q reported net sales of $152.544M, H1 sales of $281.136M, Q2 gross margin of 27.1%, diluted shares of 23.072M, cash of $70.062M, and debt components totaling about $72.649M. — investors.psiengines.com (accessed 2026-08-12)
  21. Q2 2026 release said H2 sales are expected to exceed H1 and be approximately in line with H2 2025, with strong data-center demand but continued shipment timing, throughput, supply-chain, oil-and-gas, and Wisconsin ramp-cost variability. — investors.psiengines.com (accessed 2026-08-12)
  22. Q2 call commentary discussed Wisconsin operational improvement, ongoing oil-and-gas softness, strong 2026 data-center demand, work to secure 2027 orders, and a longer-term gross margin goal in the 25% range. — stockanalysis.com (accessed 2026-08-12)
  23. Regular-session reference $51.85 at retrieval time 2026-10-21T15:04:37.142149-06:00. Market quote evidence only. (accessed 2026-10-21)

Built with Modeledge MCP

Connect your MCP client to research filings and earnings calls, then build a living financial model like this one.

Connect your agent